Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
Hussein Sultan, Yoshiko Takeuchi, Jeffrey P. Ward, et al.
Nature (2024) Vol. 632, Iss. 8023, pp. 182-191
Open Access | Times Cited: 13

Showing 13 citing articles:

CD4 T cell depletion increases memory differentiation of endogenous and CAR T cells and enhances the efficacy of Super2 and IL-33-armored CAR T cells against solid tumors
Asmaa Mohamed, David Tyler Boone, Shannon L. Ferry, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e009994-e009994
Open Access
Engineering cytokines for tumor-targeting and selective T cell activation
Kun Peng, Yang–Xin Fu, Yong Liang
Trends in Molecular Medicine (2025)
Closed Access
Recent advances and perspectives on the development of circular RNA cancer vaccines
Zhaohui Gong, Wentao Hu, Chengwei Zhou, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Trial watch: anticancer vaccination with dendritic cells
Francisca Borges, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy
Sunita Keshari, Alexander S. Shavkunov, Qi Miao, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114875-114875
Closed Access | Times Cited: 1
Bioinspired Bimetallic Ions Functionalized MOF SAzyme Nanocomposites for Synergistic Ferroptosis/Cuproptosis-Enhanced Immune Checkpoint Therapy
Linjiao Yang, Mengmeng Pan, Haofan Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The expanding universe of type I regulatory T cell biology: a new role in cancer immunotherapy
Jason Nideffer, Prasanna Jagannathan
Immunology and Cell Biology (2024)
Closed Access
The epigenetic trajectory of type 1 regulatory T cells
David P. Turicek, Xiaoxiao Wan
eLife (2024) Vol. 13
Open Access
Challenges and New Directions in Therapeutic Cancer Vaccine Development
Danjie Pan, Jiayang Liu, Xuan Huang, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1341-1341
Open Access
Genetic immune escape in cancer: timing and implications for treatment
Francisco Martínez-Jiménez, Diego Chowell
Trends in cancer (2024)
Closed Access
Leukemia escapes immunity by imposing a Type-1 regulatory program on neoantigen-specific CD4+ T cells.
Hrishi Venkatesh, Miriam Arroyo, Lynn Heltemes-Harris, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how
Yijie Zhai, Xiaoting Liang, Mi Deng
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 6, pp. 616-651
Open Access
Elimination of cDC1 cells by regulatory T cells jeopardizes cancer immunotherapy
Peng Liu, Liwei Zhao, Guido Kroemer, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Page 1

Scroll to top